Aneurysmal Subarachnoid Hemorrhage: Diagnosis and Management

Aneurysmal Subarachnoid Hemorrhage: Diagnosis and Management

Cerebrovascular Emergency Time-Critical Multidisciplinary
Executive Summary

Aneurysmal subarachnoid hemorrhage (aSAH) carries a 30-day mortality of 30 to 40 percent and accounts for up to 5 percent of all strokes, but causes disproportionately high years of life lost because most victims are younger than 60. Sudden severe thunderclap headache reaching maximum intensity within seconds, often with brief loss of consciousness, vomiting, neck stiffness, or transient focal deficit, mandates immediate non-contrast head CT. Modern third-generation scanners performed within 6 hours of headache onset have a sensitivity exceeding 99 percent, but a negative CT after 6 hours requires lumbar puncture for xanthochromia or alternative imaging. CT angiography is the first-line vascular study to localize a ruptured aneurysm and triage to definitive securing within 24 hours, ideally by endovascular coiling per ISAT trial evidence (lower 1-year disability, sustained at 10 years), with surgical clipping reserved for wide-neck, branch-incorporating, or middle cerebral artery anatomy. Pre-securing care centers on strict blood pressure control with systolic targets below 160 mmHg using continuous infusions of nicardipine or clevidipine, antifibrinolytic therapy with tranexamic acid restricted to less than 72 hours pending repair, and external ventricular drain placement for acute hydrocephalus. After securing, the dominant late risks are delayed cerebral ischemia from arterial vasospasm peaking at days 4 to 14 (mitigated by oral nimodipine 60 mg every 4 hours for 21 days), seizures, hyponatremia from cerebral salt wasting, and chronic shunt-dependent hydrocephalus. Disposition to a high-volume neurocritical care unit, transcranial Doppler surveillance, and induced hypertension or endovascular rescue for symptomatic vasospasm form the core of modern management. This guideline summarizes diagnosis, risk grading by Hunt-Hess and modified Fisher scales, definitive securing decisions, and intensive care priorities consistent with AHA/ASA 2023 and Neurocritical Care Society multidisciplinary recommendations.

30-40%
30-day mortality
>99%
CT sensitivity within 6h
<24h
Aneurysm securing window
21d
Nimodipine duration

1Pathophysiology and Risk Factors

Aneurysmal subarachnoid hemorrhage results from spontaneous rupture of a saccular (berry) aneurysm, most commonly arising at branch points of the circle of Willis where laminar shear stress is highest. The anterior communicating artery (30 to 35 percent), posterior communicating artery origin off the internal carotid (30 percent), and middle cerebral artery bifurcation (20 percent) account for the great majority of ruptures. Posterior circulation aneurysms (basilar tip, posterior inferior cerebellar artery, vertebral artery) constitute roughly 10 to 15 percent and carry distinct anatomic and treatment considerations. Mycotic, traumatic, and dissecting aneurysms represent uncommon non-saccular causes. Aneurysms develop over decades through degenerative weakening of the internal elastic lamina, with hemodynamic stress and inflammation driving outpouching. The resulting thin sac of intima and adventitia eventually ruptures, releasing arterial-pressure blood into the subarachnoid space within seconds.

Pathophysiologic cascade after rupture

Rupture causes an abrupt rise in intracranial pressure that briefly equals or exceeds mean arterial pressure, producing transient global cerebral ischemia and the characteristic loss of consciousness. Acute injury then proceeds through several phases: early brain injury during the first 72 hours (cytotoxic edema, blood-brain barrier disruption, microthrombosis, neuroinflammation), the rebleeding phase (highest risk in the first 24 hours, cumulative 4 to 13 percent within 72 hours if unsecured), and the delayed cerebral ischemia phase (days 4 to 14) driven by macrovascular vasospasm and microcirculatory dysfunction. Hydrocephalus develops in 20 to 30 percent acutely from blood obstructing arachnoid granulations or cerebrospinal fluid pathways, and 10 to 20 percent ultimately need shunting.

Modifiable and non-modifiable risk factors

  • Hypertension doubles risk; chronic uncontrolled hypertension accelerates aneurysm growth and rupture.
  • Cigarette smoking triples risk and is the single strongest modifiable factor; smoking cessation reduces rupture incidence.
  • Heavy alcohol consumption (more than 150 g/week) increases risk through hypertension and impaired vascular integrity.
  • Sympathomimetic drug use (cocaine, amphetamines) precipitates rupture via acute hypertensive surge.
  • Female sex increases risk (1.6:1 female predominance), particularly post-menopausal.
  • Family history of two or more first-degree relatives with aSAH increases lifetime risk; screening MRA recommended for asymptomatic carriers.
  • Heritable connective tissue disorders: autosomal dominant polycystic kidney disease (ADPKD), Ehlers-Danlos type IV, Marfan syndrome, and Loeys-Dietz syndrome carry markedly elevated incidence.
  • Age peaks at 50 to 60 years, but ruptures occur across adulthood; pediatric SAH is uncommon and usually associated with arteriovenous malformation rather than aneurysm.
Circle of Willis aneurysm locations Diagram showing relative frequency of aneurysm sites in the circle of Willis Common Aneurysm Locations AcomA 30-35% PcomA 30% PcomA 30% MCA 20% MCA 20% Basilar tip 5-10%
Aneurysm site distribution at the circle of Willis (anterior circulation 85 percent, posterior 10 to 15 percent)

2Clinical Presentation and Severity Grading

The hallmark clinical feature of aSAH is the thunderclap headache: a sudden, severe headache reaching maximal intensity within seconds and typically described as “the worst headache of my life.” The headache is often associated with brief loss of consciousness (in 30 to 50 percent), nausea, vomiting, neck stiffness, photophobia, and seizure (5 to 20 percent). Focal neurologic deficits suggest specific aneurysm locations: third nerve palsy (pupil-involving) classically points to a posterior communicating artery aneurysm, while abulia or akinetic mutism may follow anterior communicating artery rupture. Approximately 10 to 40 percent of patients report a “sentinel” or warning headache hours to weeks before catastrophic rupture; this minor leak represents a vital opportunity for early diagnosis often missed in primary care or emergency settings.

Severity grading scales

Three complementary scales are used to grade severity, prognosticate outcome, and guide treatment intensity. The Hunt-Hess scale is clinical (Grade I to V), the World Federation of Neurosurgical Societies (WFNS) grade combines Glasgow Coma Scale with focal deficit (Grade I to V), and the modified Fisher scale describes the radiographic blood burden and predicts vasospasm risk. Higher grades correlate strongly with worse functional outcomes and higher mortality.

GradeHunt-Hess ClinicalWFNS (GCS + Deficit)Modified Fisher CT30-day Mortality
IAsymptomatic or mild headacheGCS 15, no deficitFocal or thin SAH, no IVH5-10%
IISevere headache, no deficit (CN palsy OK)GCS 13-14, no deficitFocal/thin SAH + IVH10-15%
IIIDrowsy, mild focal deficitGCS 13-14 with deficitThick SAH, no IVH20-30%
IVStupor, hemiparesis, posturingGCS 7-12 ± deficitThick SAH + IVH40-50%
VDeep coma, decerebrateGCS 3-6 ± deficit—70-90%
⚠
Sentinel Headache

10 to 40 percent of aSAH patients report a warning headache (small leak) hours to days before major rupture. Any new severe headache reaching peak in seconds, especially in patients with risk factors (smoking, hypertension, family history), warrants non-contrast CT and a low threshold for lumbar puncture if CT is performed beyond 6 hours from onset. Missed sentinel bleeds are a leading source of malpractice litigation in stroke care.

3Diagnostic Imaging Pathway

Time-sensitive diagnosis depends on a structured imaging pathway. Non-contrast head CT is the universal first study and detects greater than 99 percent of aSAH within 6 hours of headache onset on modern third-generation scanners. Sensitivity declines progressively to 85 to 90 percent at 24 hours and below 70 percent after 5 days as blood is reabsorbed. Therefore, a negative CT performed beyond 6 hours from symptom onset does not exclude aSAH and mandates either lumbar puncture (target opening pressure measurement plus xanthochromia by spectrophotometry on the supernatant) or CT/MR angiography depending on local resources.

CT angiography

Once SAH is confirmed, CTA is the standard first vascular study to localize the ruptured aneurysm, define its size, neck width, dome-to-neck ratio, and relationship to branch vessels. Sensitivity for aneurysms larger than 3 mm exceeds 95 percent; smaller aneurysms (less than 3 mm) may be missed and warrant catheter digital subtraction angiography (DSA) if CTA is negative despite confirmed SAH. DSA remains the gold standard for vascular detail, particularly when planning endovascular treatment; 3D rotational DSA is performed during the same session as coiling.

Lumbar puncture and xanthochromia

  • Perform LP only when CT is negative and clinical suspicion remains high; obtain at least 1 mL CSF in tubes 1 and 4.
  • Persistent red blood cells in tube 4 (similar count to tube 1) supports SAH; declining count suggests traumatic tap.
  • Xanthochromia (yellow CSF supernatant from oxyhemoglobin and bilirubin breakdown) requires at least 12 hours to develop; ideally measured by spectrophotometry rather than visual inspection.
  • Negative LP performed at least 12 hours after headache onset reliably excludes aSAH.
ModalitySensitivityBest WindowIndication
Non-contrast CT>99% <6h; 85-90% at 24hWithin 6 hours of onsetFirst-line for any thunderclap headache
CT angiography95-98% (≥3 mm aneurysm)Immediately after positive CTAneurysm localization, treatment planning
Lumbar puncture (xanthochromia)~100% if >12h after onset12 hours to 2 weeks post-onsetNegative CT beyond 6h with high suspicion
Digital subtraction angiographyGold standard (>99%)Same session as endovascular treatmentNegative CTA + confirmed SAH; treatment planning
MR angiography87-95%Surveillance / pediatric / pregnancyScreening high-risk family members; follow-up
ⓘ
Angiogram-Negative SAH

In 10 to 20 percent of aSAH cases, no aneurysm is identified on initial CTA or DSA. The most favorable subtype is perimesencephalic non-aneurysmal SAH (blood centered around the brainstem cisterns, thought to be venous in origin) with excellent prognosis and low rebleeding risk. Diffuse non-perimesencephalic angiogram-negative SAH still requires repeat DSA at 1 to 2 weeks, and consideration of cervical spine MRI to exclude rare spinal source.

Aneurysmal SAH — Procedure Steps Surgical stepper: Aneurysmal SAH — Procedure Steps Aneurysmal SAH — Procedure Steps 1 Diagnosis Non-contrast CT head (sensitivity 95% within 6h, drops after); LP for xanthochromia if CT negative 2 Initial stabilization BP target SBP <160 (esmolol, labetalol, nicardipine); reverse anticoagulation; analgesia; antiemetic 3 Aneurysm securing Endovascular coiling (preferred most aneurysms — ISAT trial) OR microsurgical clipping; within 24-72 4 Vasospasm prevention Nimodipine 60mg PO q4h × 21 days (reduce by 50% if hypotensive); transcranial Doppler monitoring + s 5 Vasospasm Rx Hypertension (target SBP 160-180) for symptomatic vasospasm; intra-arterial verapamil/milrinone; ang 6 Complications Hydrocephalus: external ventricular drain → permanent shunt; SIADH/CSW: fluid management; seizures:
Aneurysmal SAH — Procedure Steps

4Pre-Securing Resuscitation and Stabilization

Before definitive aneurysm securing, the priorities are preventing rebleeding, treating hydrocephalus, and stabilizing systemic physiology. Rebleeding is the most catastrophic early complication, with a cumulative risk of 4 percent on day 1, 1 to 2 percent per day thereafter, and a 50 to 80 percent mortality if it occurs.

Blood pressure control

Strict blood pressure control reduces rebleeding risk. Maintain systolic blood pressure below 160 mmHg (or mean arterial pressure below 110 mmHg) until the aneurysm is secured. Avoid abrupt drops that could precipitate cerebral hypoperfusion. Use continuous IV infusions for titratability:

  • Nicardipine 5 mg/hr IV, titrate by 2.5 mg/hr q5-15 min, max 15 mg/hr — first-line, rapid onset, easy titration
  • Clevidipine 1-2 mg/hr IV, double q90 sec to max 16 mg/hr — ultra-short half-life, ideal for moment-to-moment control
  • Labetalol 10-20 mg IV q10 min, max 300 mg cumulative — bolus alternative
  • Avoid nitroprusside and nitroglycerin when possible (cerebral vasodilation may raise ICP)

Antifibrinolytic therapy (selected use)

In high-rebleeding-risk patients with anticipated delay to securing greater than 24 hours, short-course tranexamic acid may reduce rebleeding. Use is restricted to less than 72 hours total to avoid increased delayed cerebral ischemia and thromboembolism observed in extended treatment.

  • Tranexamic acid 1 g IV bolus, then 1 g IV q8h until aneurysm secured (max 72 h)
  • ULTRA trial (2021) showed no benefit in 6-month outcome with longer use; restrict to bridge therapy only

Hydrocephalus and external ventricular drain

Acute obstructive or communicating hydrocephalus develops in 20 to 30 percent of aSAH patients within 72 hours, presenting as decreased level of consciousness, anisocoria, or upgaze paralysis. Indications for emergent external ventricular drain (EVD):

  • Acute symptomatic hydrocephalus on serial CT
  • Hunt-Hess Grade IV-V or coma
  • Intraventricular hemorrhage with mass effect
  • Refractory intracranial hypertension

Target ICP less than 20 mmHg with cerebral perfusion pressure greater than 60 to 70 mmHg. Drain CSF intermittently or continuously with strict aseptic technique; ventriculostomy-related infection rates run 5 to 10 percent. Evaluate for permanent shunt (ventriculoperitoneal) once neurologic status stabilizes if drain weaning fails over 2 weeks.

Supportive care

  • Glucose: maintain 140 to 180 mg/dL; avoid hyper- and hypoglycemia which worsen brain injury.
  • Temperature: aggressive normothermia (acetaminophen, cooling) — fever worsens outcome, with each degree above 37.5°C linked to delayed cerebral ischemia and worse modified Rankin score.
  • Sodium: monitor q6-12h; hyponatremia from cerebral salt wasting is common (30 to 50 percent), treat with isotonic or hypertonic saline rather than fluid restriction.
  • VTE prophylaxis: mechanical compression devices initially; pharmacologic VTE prophylaxis (enoxaparin 40 mg SC daily) typically delayed 24 hours after securing.
  • Anticonvulsants: short-course (3-7 days) phenytoin or levetiracetam in high-grade SAH or with cortical involvement; routine prolonged use not recommended.

5Definitive Treatment: Coiling vs Clipping

Aneurysm securing should be performed within 24 hours of presentation whenever feasible. Two definitive options exist: endovascular coiling (with or without stent or balloon assistance) and microsurgical clipping. The International Subarachnoid Aneurysm Trial (ISAT, 2002) and its long-term follow-up demonstrated significantly lower 1-year and 10-year disability and dependency with coiling for aneurysms anatomically suitable for both approaches, leading to coiling becoming the default first-line treatment in most centers.

ApproachBest Suited ForAdvantagesDisadvantages
Endovascular Coiling (1st line)Posterior circulation; narrow neck; elderly; poor surgical candidates; ISAT-favorable anatomyLower disability/dependency at 1y/10y (ISAT); shorter hospital stay; less invasiveHigher retreatment rate (~10%); annual angiographic follow-up; not all anatomy amenable
Surgical ClippingMCA bifurcation; wide-neck; branch-incorporating; large hematoma needing evacuation; failed coilingHigher complete occlusion rate (~95%); single definitive treatment; best for MCACraniotomy invasiveness; higher early disability; requires high-volume neurosurgical center
Stent-assisted coiling / Flow diverterWide-neck or fusiform aneurysms; large/giant ICA aneurysms (Pipeline)Treats anatomy not amenable to standard coiling; high long-term occlusionRequires dual antiplatelet therapy (problematic in acute SAH with EVD)
Conservative observationSmall (<7 mm) unruptured incidental aneurysms in elderly; perimesencephalic non-aneurysmal SAHAvoids procedural riskRisk of future rupture; ongoing surveillance imaging
⚕
When to Refer to a Comprehensive Stroke Center

All confirmed aSAH patients should be transferred to a high-volume comprehensive stroke center with 24/7 endovascular and neurosurgical capability, dedicated neurocritical care, and multidisciplinary team experience (volume threshold of at least 35 aSAH cases per year is associated with lower mortality). Initiate transfer immediately on confirmation of SAH on CT — do not delay for CTA at outside facility. While arranging transfer, control blood pressure with nicardipine, ensure airway protection in low-GCS patients, and contact the receiving neurointerventional and neurosurgical teams concurrently. Aneurysm securing within 24 hours improves outcomes; transfer-related delays beyond 24 hours significantly increase rebleeding risk.

Treatment algorithm flow

Subarachnoid hemorrhage treatment algorithm Flowchart from thunderclap headache through CT, CTA, and securing Aneurysmal SAH Treatment Algorithm Thunderclap Headache Sudden, max in seconds Non-Contrast Head CT Immediately on arrival CT positive for SAH? (Or LP+ if >6h) Yes Negative + suspicion CT Angiography Localize aneurysm LP / MRA / Repeat imaging Xanthochromia spectrophotometry Secure aneurysm within 24 h Coiling preferred (ISAT) — Clipping for MCA/wide neck NeuroICU: BP <160, EVD if hydrocephalus Nimodipine 60 mg q4h x 21d, monitor vasospasm If diffuse SAH despite negative angio Repeat DSA at 1-2 weeks Perimesencephalic SAH Excellent prognosis No securing needed
From thunderclap headache through CT/CTA to securing within 24 hours and ICU care

Practice Insights: Lessons From the Bedside

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)The hour at which a ruptured aneurysm gets secured is set by a neurosurgical rota and a transfer distance, both invisible in the notes, and SAH is best understood less as a single disease and more as four overlapping danger windows — the re-rupture window before securing, the vasospasm/DCI window from day 4 to day 14, the hyponatremia window starting around day 3, and the cardiopulmonary stunning window in the first 72 hours. The worst outcomes rarely come from missing the diagnosis on initial CT; they come from underestimating one of these windows after the aneurysm was already coiled and the family had been told the patient was “out of the woods.”

What the Guideline Misses

Algorithms anchor on “thunderclap headache as worst of life,” but in experienced practice fewer than two in three confirmed SAH patients use that exact descriptor. The phrase that has correlated better in experienced hands is “instant onset, like a switch flipped” — temporal abruptness predicts SAH more reliably than peak intensity. It is worth mining the history for sentinel events: roughly one in three patients can recall a similar but milder headache in the preceding 2–8 weeks, and that warning leak is the moment intervention would have been most curative.

Patterns That Recur

The cardiac stunning of the first 72 hours catches new trainees off guard — apical ballooning, troponin rise, transient EF drop into the 20s — and teams routinely escalate to a cardiology consult while the actual problem is sympathetic surge from the bleed itself. By contrast, the vasospasm/DCI wave from day 4 onward is anticipated but still under-acted-on; the new focal deficit at 7 AM on hospital day 6 is rarely heralded by an obvious imaging change.

A Practical Bedside Heuristic

Any abrupt-onset severe headache gets a non-contrast CT within 30 minutes — full stop — and if that CT is negative within 6 hours of onset and the clinical suspicion remains moderate-to-high, the next step is lumbar puncture rather than accepting a normal CT as ruling SAH out. Too many “improving” patients walk back into the ED 48 hours later with a Hunt-Hess IV bleed from the same unsecured aneurysm.

The Sodium Doctrine

The CSW versus SIADH distinction lives at the bedside, not in the lab. The preferred approach is to anchor on volume status — orthostatic vitals, neck veins, urine output trajectory — before looking at serum and urine sodium. CSW patients are dry and salt-losing and need salt plus volume; SIADH patients are euvolemic-to-overloaded and need fluid restriction. Treating CSW as SIADH by restricting fluid is a well-recognized route to severe delayed cerebral ischemia.

Illustrative Scenario

A woman in her early fifties presented after a sudden severe headache during exertion, described not as the worst pain she had felt but as “the most wrong feeling she had ever had in her head,” accompanied by transient loss of consciousness with full recovery before EMS arrival. Initial Hunt-Hess was II, modified Fisher 3 on CT, and a 6 mm anterior communicating artery aneurysm was identified on CTA. The aneurysm was secured by endovascular coiling within 11 hours of ictus. She did well until hospital day 7, when the morning examination showed subtle right-arm pronator drift and word-finding pause — vasospasm by transcranial Doppler, confirmed on DSA. Induced hypertension to MAP 110 and intra-arterial verapamil were given, and she returned to her neurological baseline by hospital day 10. On further history, she recalled a similar but briefer headache three weeks prior that she had attributed to “a bad migraine.”

The takeaway: a transient LOC after a sudden headache — even with full recovery — is SAH until proven otherwise, and the “bad migraine” three weeks earlier was almost certainly the sentinel leak worth asking about explicitly.

Protocol Adjustments to the Standard Pathway

  1. Door-to-CT under 30 minutes for any abrupt-onset severe headache, even when triage labels it “migraine” or “tension.” If the CT is negative within 6 hours of onset and suspicion remains, a negative CT should not be accepted as the end of the workup — lumbar puncture or CTA follows. The cost of one extra LP is far less than the cost of one missed sentinel bleed.
  2. Pre-securing systolic blood pressure target under 140 mmHg via nicardipine drip, not labetalol boluses. The smoother titration of a continuous infusion has, in experienced hands, produced fewer spikes during transport and imaging, and re-rupture rates trend lower when SBP variability is minimized rather than just the mean controlled.
  3. Aneurysm securement within 24 hours of ictus whenever feasible, with coiling preferred when both modalities are reasonable per ISAT-derived thinking. Every additional hour before securement compounds re-rupture risk, and “tomorrow morning at the start of the OR list” has produced too many preventable re-bleeds.
  4. Nimodipine 60 mg PO every 4 hours for the full 21 days — never reduced for borderline blood pressure, never extended past 21 days. Split-dosing to 30 mg every 2 hours is preferable if hypotension forces a change, rather than reducing total daily dose, because the survival/functional-outcome benefit from nimodipine is dose-dependent and the temptation to “hold one dose” compounds over weeks.
SAH Four-Window Danger Map Re-rupture, cardiac stunning, vasospasm/DCI, and sodium-handling windows across the first 21 days post-SAH Four Danger Windows of SAH — Day 0 to Day 21 Bedside watch points across each phase of post-bleed care Day 0 Day 3 Day 7 Day 14 Day 21 RE-RUPTURE Pre-securement; peak first 24h Action: SBP <140, secure <24h CARDIAC STUNNING Sympathetic surge; first 72h Action: echo, expect transient EF drop VASOSPASM / DCI Day 4–14 peak; TCD daily, exam q1h Action: nimodipine 60mg q4h × 21d, induced HTN if deficit SODIUM HANDLING: CSW vs SIADH (day 3–14) ★ DCI deficits appear before TCD changes — exam q1h beats imaging
The four overlapping danger windows clinicians monitor explicitly day-by-day after every SAH (gold accent marks the bedside priority that outweighs imaging).

6Post-Securing Critical Care, Vasospasm, and FAQ

After the aneurysm is secured, the dominant late risks shift to delayed cerebral ischemia, hydrocephalus, hyponatremia, and seizure. Patients should remain in a dedicated neurocritical care unit for 14 to 21 days for intensive monitoring through the vasospasm window.

Vasospasm and delayed cerebral ischemia (DCI)

Macrovascular vasospasm peaks at days 4 to 14 after rupture and is detected radiographically in 60 to 70 percent and clinically in 20 to 40 percent of patients. Delayed cerebral ischemia, the clinical syndrome of new focal deficit or unexplained decline in consciousness, occurs in 20 to 30 percent and accounts for substantial late morbidity.

  • Nimodipine 60 mg PO/NG q4h x 21 days — start within 96 hours, continue regardless of blood pressure (reduce to 30 mg q2h if hypotensive). Reduces DCI and improves outcome.
  • Transcranial Doppler: surveillance daily for MCA mean velocity; greater than 200 cm/s or Lindegaard ratio greater than 6 suggests severe vasospasm.
  • Maintain euvolemia (avoid prophylactic hypervolemia/hemodilution per HHH triad — abandoned).
  • Symptomatic vasospasm: induced hypertension (target SBP 160-220 mmHg with norepinephrine titration), and if refractory, endovascular rescue with intra-arterial verapamil/nicardipine or balloon angioplasty.

Hyponatremia and electrolyte management

Hyponatremia develops in 30 to 50 percent of aSAH patients, most often from cerebral salt wasting (renal sodium loss with hypovolemia) rather than SIADH. Distinction matters: cerebral salt wasting requires sodium and volume replacement, while SIADH requires fluid restriction (potentially harmful in SAH).

  • Assess volume status carefully (orthostatic vitals, central venous pressure, fluid balance).
  • Treat with isotonic saline as default; add hypertonic 3% saline (target sodium 135-145) for moderate hyponatremia.
  • Fludrocortisone 0.1 to 0.4 mg PO daily reduces sodium loss in cerebral salt wasting.
  • Avoid fluid restriction unless SIADH is unequivocal.

Long-term complications and follow-up

  • Chronic hydrocephalus: 10 to 20 percent require permanent ventriculoperitoneal shunt.
  • Seizure: 5 to 25 percent develop seizures; 5 to 10 percent develop chronic epilepsy. Anticonvulsant prophylaxis is short-course only.
  • Cognitive sequelae: executive dysfunction, memory impairment, and depression are common in survivors; refer to neuropsychological assessment and cognitive rehabilitation.
  • Aneurysm surveillance: annual MRA after coiling for 5 years (retreatment rate ~10%); CTA at 6 months and 5 years after clipping.
  • Family screening: MRA for first-degree relatives if 2+ family members affected (especially before age 50).
Pearl

Continue nimodipine 60 mg every 4 hours for the full 21-day course even if blood pressure dips. Halve the dose to 30 mg every 2 hours for hypotension rather than discontinuing. Skipping or stopping early is a leading cause of preventable delayed cerebral ischemia. Nimodipine works through multiple mechanisms beyond vasodilation (neuroprotection, microcirculatory improvement) — its benefit on outcome is independent of vessel diameter changes on angiography.

Pitfall

Restricting fluids to treat hyponatremia in aSAH worsens outcomes. The default cause is cerebral salt wasting (renal sodium loss with hypovolemia), not SIADH. Volume contraction precipitates delayed cerebral ischemia. Treat with isotonic or hypertonic saline plus fludrocortisone, and reserve fluid restriction only for unequivocal SIADH (high urine sodium with euvolemia). Document volume status carefully before any restriction.

Frequently Asked Questions

What is the time window for securing a ruptured cerebral aneurysm?
Aneurysm securing within 24 hours of presentation is recommended whenever feasible because rebleeding risk is highest in the first 24 hours (4 percent on day 1, 1 to 2 percent per day thereafter, with 50 to 80 percent mortality if it occurs). Delays beyond 72 hours significantly worsen outcomes. Transfer to a comprehensive stroke center should not wait for outside CTA.
Should clinicians order CTA or jump straight to digital subtraction angiography?
CT angiography is the standard first vascular study after positive non-contrast CT — it has greater than 95 percent sensitivity for aneurysms 3 mm or larger and provides treatment planning data quickly with less invasiveness than DSA. Digital subtraction angiography is performed at the time of endovascular treatment for highest-resolution detail and 3D rotational imaging, and is reserved as the next test if CTA is negative despite confirmed SAH.
When is lumbar puncture needed for suspected SAH?
LP is needed when non-contrast CT performed beyond 6 hours from headache onset is negative but clinical suspicion remains high. Within 6 hours of onset, a negative third-generation CT essentially excludes SAH (sensitivity over 99 percent). Beyond 6 hours, sensitivity declines and xanthochromia by spectrophotometry on CSF collected at least 12 hours after onset is the diagnostic standard. Persistent red blood cells in tube 4 of LP also support SAH.
Is nimodipine started intravenously or orally?
Nimodipine is given enterally (60 mg PO or NG every 4 hours for 21 days). Intravenous formulation is not approved in the United States because of severe hypotension risk. If a patient is intubated, deliver via nasogastric or orogastric tube — do not skip doses for nil per os status during procedures longer than the dosing interval.
Should antifibrinolytic therapy be used routinely?
Tranexamic acid is reserved for short-course bridge therapy (less than 72 hours) when securing is delayed. The ULTRA trial (2021) showed no improvement in 6-month outcomes with extended use, and prolonged therapy increases delayed cerebral ischemia and thromboembolic risk. Stop tranexamic acid immediately when the aneurysm is secured.
How long should patients stay in neurocritical care?
Most patients require 14 to 21 days in dedicated neurocritical care to span the full vasospasm window (peak days 4 to 14). Higher-grade SAH (Hunt-Hess IV-V) and patients with EVD-dependent hydrocephalus often need 3 to 4 weeks. Transfer to a step-down unit is appropriate once vasospasm risk has resolved and EVD is weaned.
Should family members be screened for unruptured aneurysms?
Screening with MR angiography is recommended for first-degree relatives when two or more family members have had aSAH or unruptured aneurysm, particularly before age 50. Single affected first-degree relative does not justify routine screening unless additional risk factors (smoking, hypertension, ADPKD) are present. Screening typically begins around age 30 and repeats every 5 years.
GUIDELINE REFERENCES

Primary guideline documents this article draws on. Links resolve via DOI to the publisher; access may require a subscription.

Leave a Reply

Your email address will not be published. Required fields are marked *